How did McKesson's other fees evolve over the past year?

McKesson's other fees, as reported in the past year, did not exhibit a significant or consistent trend. The data for other fees is not available for the specific periods in the referenced earnings calls, nor is it detailed in the annual reports or financial statements. Therefore, it is not possible to provide a detailed analysis of the evolution of McKesson's other fees over the past year based on the available data.

However, it is important to note that McKesson's overall financial performance has been strong, with solid growth in key segments such as the U.S. pharmaceutical and prescription technology solutions segments. The company's focus on strategic partnerships, new product introductions, and operational efficiencies likely had an impact on its financial outcomes, including potential fluctuations in other fees. Investors should consider these broader contextual factors when assessing McKesson's financial performance over the past year.